https://sputnikglobe.com/20220317/evaluation-of-russian-sputnik-v-vaccine-in-eu-continues-ema-says--1093970485.html

Evaluation of Russian Sputnik V Vaccine in EU Continues, EMA Says

Sputnik International

BRUSSELS (Sputnik) - The European Medicines Agency (EMA) continues the procedure for a gradual examination of the Russian anti-coronavirus vaccine Sputnik V... 17.03.2022, Sputnik International

2022-03-17T17:38+0000

2023-04-12T17:09+0000

european medicines agency

russia

sputnik v vaccine

european union (eu)

https://cdn1.img.sputnikglobe.com/img/105928/43/1059284360_0:294:3978:2532_1920x0_80_0_0_04f18774245d2908ae2ca260a7e3abf0.jpg

At the same time, there is currently no active phase in the examination, it said.Sputnik V has been under review by the EMA since March 2021. Hungary and Slovakia approved the vaccine without waiting for EMA authorisation.Sputnik V, the world's first registered vaccine against the COVID-19 infection, was unveiled on 11 August 2020, following Phase 1 and 2 clinical trials. Phase 3 clinical trial results were published in the Lancet magazine on 2 February 2021. The vaccine is based on a well-studied human adenovirus vector platform. The efficacy of Sputnik V has been proven at 97.6%, based on the analysis of data on the occurrence of the COVID-19 infection among Russians vaccinated with both components from December 2020 to late March 2021.Sputnik V has already been authorised in 71 countries with a total population of more than 4 billion people.

russia

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

2022

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

News

en_EN

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

1920

1080

true

1920

1440

true

https://cdn1.img.sputnikglobe.com/img/105928/43/1059284360_105:0:3873:2826_1920x0_80_0_0_089e9d185a25e4414c05e90e8210c912.jpg

1920

true

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

Sputnik International

european medicines agency, russia, sputnik v vaccine, european union (eu)

Evaluation of Russian Sputnik V Vaccine in EU Continues, EMA Says

17:38 GMT 17.03.2022 (Updated: 17:09 GMT 12.04.2023)

© AP Photo / Frank AugsteinThe headquarters building of the European Medicines Agency, EMA, left, in London. Brexit is still well over year away but two cities on Monday, Nov. 20, 2017 will already be celebrating Britain's departure from the European Union

The headquarters building of the European Medicines Agency, EMA, left, in London. Brexit is still well over year away but two cities on Monday, Nov. 20, 2017 will already be celebrating Britain's departure from the European Union - Sputnik International, 1920, 17.03.2022

BRUSSELS (Sputnik) - The European Medicines Agency (EMA) continues the procedure for a gradual examination of the Russian anti-coronavirus vaccine Sputnik V, the regulator told Sputnik.

At the same time, there is currently no active phase in the examination, it said.

Sputnik V has been under review by the EMA since March 2021. Hungary and Slovakia approved the vaccine without waiting for EMA authorisation.

Sputnik V, the world's first registered vaccine against the COVID-19 infection, was unveiled on 11 August 2020, following Phase 1 and 2 clinical trials. Phase 3 clinical trial results were published in the Lancet magazine on 2 February 2021. The vaccine is based on a well-studied human adenovirus vector platform. The efficacy of Sputnik V has been proven at 97.6%, based on the analysis of data on the occurrence of the COVID-19 infection among Russians vaccinated with both components from December 2020 to late March 2021.

Sputnik V has already been authorised in 71 countries with a total population of more than 4 billion people.